Novo Nordisk Bullish as Demand For Blockbuster Drugs Soars 0 02.05.2024 09:45 The Wall Street Journal The Danish pharmaceutical giant raised its full-year guidance to reflect better pricing in the U.S. and as global demand for its hit weight-loss and diabetes drugs continues to outstrip supply. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
